Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2025-12-25 @ 5:21 PM
Study NCT ID:
NCT03518203
Status:
COMPLETED
Last Update Posted:
2023-09-21
First Post:
2018-03-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients
Sponsor:
Children's Hospital Medical Center, Cincinnati
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-03
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-05
First Submit QC Date:
None
Study First Post Date:
2018-05-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-05-30
Results First Submit QC Date:
None
Results First Post Date:
2023-09-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-20
Last Update Post Date:
2023-09-21
Last Update Post Date Type:
ACTUAL